...
首页> 外文期刊>Acta Medica Transilvanica >REEVALUAREA PERFORMAN?ELOR DETERMIN?RII ANTICORPILOR ANTIOVARIENI ?N DIAGNOSTICUL INSUFICIEN?EI OVARIENE PREMATURE LA PACIENTELE CU BOAL? TIROIDIAN? AUTOIMUN?
【24h】

REEVALUAREA PERFORMAN?ELOR DETERMIN?RII ANTICORPILOR ANTIOVARIENI ?N DIAGNOSTICUL INSUFICIEN?EI OVARIENE PREMATURE LA PACIENTELE CU BOAL? TIROIDIAN? AUTOIMUN?

机译:在评估疾病患者早产卵巢功能不全中抗卵巢抗体测定性能的重新评估?甲状腺?自身免疫?

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: To reassess the antiovarian antibodies test performance in the diagnosis of premature ovarian failure of the patients with autoimmune thyroid disease. Material and method: The study involved 70 patients with autoimmune thyroid disease, from which ten cases (10/70, 14.4%) were associated with premature ovarian failure and were found to have serum antiovarian antibodies, using as reagent a mixture of ovarian proteins; the values greater than 10 IU/mL were considered positive. Results: Antiovarian antibodies were positive in one case (1,4%, 1/70) and was not a case of premature ovarian failure; in the same case antinuclear antibodies were positive. Conclusions: Determination of the circulating antiovarian antibodies as a possible predictive factor for premature ovarian failure is not really sustained, especially because it doesn’t exist a recognized specific marker of the ovarian autoimmunity, and the study results are statistically insignificant.
机译:目的:重新评估抗卵巢抗体检测在自身免疫性甲状腺疾病患者卵巢早衰诊断中的作用。资料和方法:该研究涉及70例自身免疫性甲状腺疾病患者,其中10例(10/70,14.4%)与卵巢早衰有关,并被发现具有血清抗卵巢抗体,使用卵巢蛋白混合物作为试剂。大于10 IU / mL的值视为阳性。结果:抗卵巢抗体阳性1例(1.4%,1/70),不是卵巢早衰的一例。在相同情况下,抗核抗体为阳性。结论:确定循环中的抗卵巢抗体作为卵巢早衰的可能预测因素并不能真正持续,特别是因为它不存在公认的卵巢自身免疫特异性标志物,并且该研究结果在统计学上不重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号